Joint Formulary & PAD

Ondansetron hydrochloride - Nausea and vomiting (pregnancy)

I agree that in using this database I understand that this platform only provides guidance on local prescribing policy and that all prescribing decisions are ultimately the responsibility of the clinician.

Status 1

Green (see narrative)
Formulations :
  • Tablets
Associated Icons :
Restrictions / Comments :
Important
2nd line treatment option. Should not be prescribed for longer than 5 days and not recommended in the first trimester.
 

Status 2

Green (see narrative)
Formulations :
  • Orodispersible films
Associated Icons :
Restrictions / Comments :
Important
An option in patients with swallowing difficulties. 2nd line treatment option. Should not be prescribed for longer than 5 days and not recommended in the first trimester.
 

Status 3

Non Formulary
Formulations :
  • Oral solution
  • Oro-dispersible
Associated Icons :
Restrictions / Comments :
Important

Orodispersible films are a more cost effective option than oral solution and orodispersible tablets.

PAD Profile

ChemicalSubstance :
Ondansetron hydrochloride
Indication :
Nausea and vomiting (pregnancy)
Group Name :
Keywords :
Brand Names Include :
Important Information :
Latest Additions Date From :
Latest Additions Date To :
Supporting Documents :
1
Traffic Light Entries :
3

Other Indications

Below are listed other indications that Ondansetron hydrochloride is used to treat.

Committee Recommendations (1)

The Surrey Heartlands APC agreed a traffic light status and place in therapy for drugs used to treat nausea and vomiting in pregnancy.

Visit  the Guideline Profile page for a full list of these drugs and to access the CKS guidelines for nasea & vomiting and pregnancy and the BUMPS website (Best Use of Medicines in Pregnancy).